Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: PeptiDream Inc.

Capitalization 188B 1.19B 1.03B 928M 890M 1.62B 110B 1.69B 10.96B 4.39B 52.52B 4.47B 4.38B P/E ratio 2025
-57.1x
P/E ratio 2026 * 11.5x
Enterprise value 162B 1.02B 882M 796M 763M 1.39B 94.16B 1.45B 9.4B 3.77B 45.04B 3.84B 3.75B EV / Sales 2025
11.6x
EV / Sales 2026 * 3.69x
Free-Float
74.01%
Yield 2025 *
-
Yield 2026 * -
1 day+3.91%
1 week+10.86%
Current month+6.31%
1 month-3.13%
3 months-9.47%
6 months-12.65%
Current year-8.51%
1 week 1,310
Extreme 1310
1,517.5
1 month 1,310
Extreme 1310
1,587
Current year 1,310
Extreme 1310
1,788
1 year 1,310
Extreme 1310
2,365.5
3 years 1,039
Extreme 1039
3,060
5 years 1,039
Extreme 1039
5,560
10 years 1,039
Extreme 1039
6,540
Manager TitleAgeSince
Chief Executive Officer 51 31/12/2021
Director of Finance/CFO 48 31/12/2021
Chief Operating Officer 56 31/12/2021
Director TitleAgeSince
Director/Board Member 51 31/07/2008
Director/Board Member 76 31/08/2015
Director/Board Member 82 31/08/2015
Change 5d. change 1-year change 3-years change Capi.($)
+2.88%+10.86%-29.74%-17.64% 1.21B
+1.35%-2.89%+13.54%+95.35% 44.16B
-2.36%-5.14%+45.74%+12.82% 40.5B
+2.14%-2.18%+91.12%+653.32% 30.21B
+0.65%-4.95%-6.09%-19.74% 25.47B
+2.09%-2.27%+52.25%-30.46% 19.22B
-0.20%-7.38%+3.95%-31.19% 16.5B
+10.70%+15.22%+64.33%+191.86% 12.64B
+4.04%-2.90%-11.59%+1,007.04% 11.72B
+7.79%+16.85%+66.91% - 11.51B
Average +3.03%-2.66%+29.04%+206.82% 21.31B
Weighted average by Cap. +1.69%-3.44%+35.32%+183.82%

Financials

2025 2026 *
Net sales 18.68B 118M 102M 92.01M 88.18M 160M 10.88B 168M 1.09B 436M 5.21B 443M 434M 47.9B 303M 261M 236M 226M 411M 27.9B 430M 2.79B 1.12B 13.35B 1.14B 1.11B
Net income -4.02B -25.41M -21.92M -19.8M -18.97M -34.48M -2.34B -36.05M -234M -93.73M -1.12B -95.4M -93.35M 16.47B 104M 89.83M 81.12M 77.74M 141M 9.59B 148M 958M 384M 4.59B 391M 383M
Net Debt -26.83B -170M -146M -132M -127M -230M -15.63B -241M -1.56B -626M -7.48B -637M -623M -11.85B -74.92M -64.63M -58.36M -55.93M -102M -6.9B -106M -689M -276M -3.3B -281M -275M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
751
Date Price Change Volume
10/03/26 1,500.50 ¥ +2.88% 530,300
09/03/26 1,458.50 ¥ -1.52% 1,138,900
06/03/26 1,481.00 ¥ +5.00% 1,488,000
05/03/26 1,410.50 ¥ +6.73% 1,566,900
04/03/26 1,321.50 ¥ -3.33% 1,822,400
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,458.50JPY
Average target price
3,008.33JPY
Spread / Average Target
+106.26%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW